slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 27,481-27,510
Pages 1,371
Rows per page 30
Component
27,481-27,510 of 41,127
36
Foxo | Investor Presentation Deck | 36 slidesFoxo | Investor Presentation Deck | 36 slides · FOXO
Pitch deck Investor relations Beat · Action1 hit
17
The slide uses a three-column layout to summarize financials, community/brand presence, and global reach.Hydrafacial | Investor Day Presentation Deck | 149 slides · BeautyHealth
Conference presentation Investor relations Beat · Need1 hit
103
The chart tracks the evolution of EBITDA guidance over time, highlighting the growth from 2021 outlooks to the 2022 outlook.Hydrafacial | Investor Day Presentation Deck | 149 slides · BeautyHealth
Conference presentation Investor relations Beat · Action1 hit
113
Includes a disclaimer regarding non-GAAP measures and forward-looking statements.Hydrafacial | Investor Day Presentation Deck | 149 slides · BeautyHealth
Conference presentation Investor relations Beat · Action1 hit
114
The chart uses dashed lines to indicate projections for both metrics, showing a range of potential outcomes for EBITDA margin.Hydrafacial | Investor Day Presentation Deck | 149 slides · BeautyHealth
Conference presentation Investor relations Beat · Action1 hit
04
The table shows the impact of accounting adjustments on key financial metrics like EBITDA, Depreciation, and Profit Before Tax.JD Sports | Results Presentation Deck | 38 slides · JD Group
Conference presentation Investor relations Beat · Need1 hit
05
The table provides a comparative view of financial performance across five fiscal years (2018-2022).JD Sports | Results Presentation Deck | 38 slides · JD Group
Conference presentation Investor relations Beat · Need1 hit
02
Levi Strauss | Investor Presentation Deck | 49 slidesLevi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations 1 hit
22
The slide uses a bar chart to show revenue growth and a callout to highlight the absolute dollar increase and CAGR.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
26
The slide uses a map graphic as a background element to reinforce the 'International' theme.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
33
LSD = Low Single Digits, MSD = Mid Single Digits, HSD = High Single Digits. The chart visualizes the shift from 4-6% to 6-8% CAGR.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
02
LumiraDx | Investor Presentation Deck | 55 slidesLumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
05
The slide features the LumiraDx device on the right and a series of test cartridge icons on the left.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
12
The slide uses a color-coded border system to distinguish between test types (Qualitative/Quantitative Immunoassay, Enzyme, Molecular).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
13
The chart uses a Gantt-style visualization to show progress across different diagnostic modalities.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
14
The slide showcases the physical device and a series of color-coded test cartridges for various conditions (COVID-19, HbA1c, D-Dimer, etc.).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
27
The slide uses a blue dashed box to highlight key differentiators for the company's product.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Evidence1 hit
33
The table shows a progression from Year 1 to Year 2, and a second Year 2 column, likely representing a ramp-up or optimization scenario.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
34
The slide uses a product-centric layout to demonstrate market readiness and addressable market size for a portfolio of diagnostic tests.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
35
The slide uses a Gantt-style chart to visualize development stages (Concept to Regulatory) for multiple product lines.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
36
The slide uses a color-coded legend to distinguish between testing methodologies (Immunoassay, Molecular, Enzyme, Metabolic/Electrochemical).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
41
The slide uses a process-like flow to categorize product applications.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
44
The slide highlights current reach and future expansion plans into major diagnostics markets.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
49
The slide displays the LumiraDx point-of-care diagnostic platform alongside a row of various test cartridges.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
53
The slide displays the LumiraDx platform hardware alongside a row of 10 distinct test cartridges (SARS-CoV-2 variants, HbA1c, D-Dimer, INR, NT-proBNP, CRP).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
55
This is a transition or filler slide used for branding.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
07
Market data as of 9/27/2022.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
05
The chart shows Orange outperforming the selected peer groups and the S&P 500 index over the specified period.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Benchmark Gap1 hit
06
Includes annotations for specific dates and events impacting stock price.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Benchmark Gap1 hit
07
Includes valuation ranges for Street Case and Management Case scenarios, with a reference line at $19.41.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Benchmark Gap1 hit